Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier-Reference-Cited by-同舟云学术

Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier

Published:2017-11-07 Issue:4 Volume:60 Page:1547-1565
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

André Séverine¹,Ansciaux Emilie¹,Saidi Elamine¹,Larbanoix Lionel²,Stanicki Dimitri¹,Nonclercq Denis³,Vander Elst Luce¹,Laurent Sophie¹²,Muller Robert N.¹²,Burtea Carmen¹

Affiliation:

1. Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, Mons, Belgium

2. Center for Microscopy and Molecular Imaging, Gosselies, Belgium

3. Laboratory of Histology, University of Mons, Mons, Belgium

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference43 articles.

1. Modeling test and treatment strategies for presymptomatic Alzheimer disease;Burke;PLoS One,2014

2. Biomarkers in Alzheimer’s disease: A review;Chintamaneni;ISRN Pharmacol,2012

3. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer’s disease;Barage;Neuropeptides,2015